Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab-related cardiotoxicity in the herceptin adjuvant trial.
Montemurro F, Redana S, Valabrega G, Martinello R, Aglietta M, Palmiero R. Montemurro F, et al. J Clin Oncol. 2008 Apr 20;26(12):2052-3; author reply 2053-4. doi: 10.1200/JCO.2007.15.5044. J Clin Oncol. 2008. PMID: 18421060 No abstract available.
Trastuzumab-based combination therapy for breast cancer.
Montemurro F, Valabrega G, Aglietta M. Montemurro F, et al. Expert Opin Pharmacother. 2004 Jan;5(1):81-96. doi: 10.1517/14656566.5.1.81. Expert Opin Pharmacother. 2004. PMID: 14680438 Review.
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.
Ballestrero A, Montemurro F, Gonella R, Capaldi A, Danova M, Friedman D, Puglisi M, Aglietta M, Patrone F. Ballestrero A, et al. Among authors: montemurro f. Breast Cancer Res Treat. 2003 Dec;82(3):185-90. doi: 10.1023/B:BREA.0000004374.72658.17. Breast Cancer Res Treat. 2003. PMID: 14703065 Clinical Trial.
262 results